Anders Ullén
Adjunct Professor | Docent
E-mail: anders.ullen@ki.se
Visiting address: Karolinska Universitetssjukhuset, Karolinska Institutet Solna, D1:05, 17176 Stockholm
Postal address: K7 Onkologi-Patologi, K7 Forskning Ullen, 171 77 Stockholm
Part of:
About me
- Adjunct Professor of Clinical Oncology at the Department of
Oncology-Pathology as of 1 July 2021. Primary position: Senior physician at
Department of Pelvic Cancer, Theme Cancer, Karolinska University Hospital
Research
- Anders Ullén is a clinical oncologist with research focused within the area
of genitourinary oncology – i. e. cancers of the genital and urinary
systems. He is specifically driven by the goal to improve management and
outcome for patients with advanced urothelial cancer.
Ullén’s research is typically translational and spans from preclinical
studies to prospective clinical trials, with the goal of identifying
treatment-predictive biomarkers and developing new therapeutic options and
precision-based treatment approaches for these patients. Several new systemic
treatments, such as chemotherapies, immunotherapies and targeted drugs, have
been evaluated in prospective phase I – phase III trials, in different
phases of the disease and in national and international collaborations with
findings that are of relevance for everyday clinical practice. Furthermore,
Ullén’s team is interested in how specific genetic aberrations and the
spatial distribution of different cell types in the tumour influence
therapeutic out- come and prognosis.
Articles
- Article: BJU INTERNATIONAL. 2024;134(2):229-238
- Article: EUROPEAN UROLOGY. 2024;85(2):154-163
- Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2024;59:19-25
- Article: INTERNATIONAL JOURNAL OF CANCER. 2024;154(1):180-190
- Article: CLINICAL GENITOURINARY CANCER. 2023;21(6):e438-e448
- Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2023;57(1-6):15-21
- Article: EUROPEAN UROLOGY. 2023;84(1):95-108
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(19):3486-3492
- Article: EJSO. 2023;49(4):868-874
- Article: EUROPEAN JOURNAL OF CANCER. 2023;181:198-207
- Article: CLINICAL GENITOURINARY CANCER. 2023;21(1):107.e1-107.e9
- Article: BMJ OPEN. 2022;12(12):e064898
- Article: ACTA ONCOLOGICA. 2022;61(10):1179-1185
- Article: MOLECULAR ONCOLOGY. 2022;16(20):3620-3641
- Article: FUTURE ONCOLOGY. 2022;18(19):2361-2371
- Article: EUROPEAN UROLOGY. 2022;81(5):523-532
- Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2022;56(2):137-146
- Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2022;56(1):27-33
- Article: PLOS ONE. 2022;17(9):e0274859
- Article: ACTA ONCOLOGICA. 2021;60(10):1301-1307
- Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2021;55(5):361-365
- Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2021;48(10):3325-3334
- Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2021;55(4):276-280
- Article: BLADDER CANCER. 2021;7(2):161-171
- Article: NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(13):1218-1230
- Article: JOURNAL OF NUCLEAR MEDICINE. 2020;61(5):671-675
- Article: EUROPEAN JOURNAL OF CANCER. 2020;127:173-182
- Article: WORLD JOURNAL OF UROLOGY. 2020;38(2):381-388
- Article: ONCOLOGIST. 2019;24(6):745-e213
- Article: CLINICAL CANCER RESEARCH. 2019;25(6):1766-1773
- Article: GENOME MEDICINE. 2018;10(1):85
- Article: INVESTIGATIONAL NEW DRUGS. 2018;36(4):615-618
- Article: EUROPEAN JOURNAL OF CANCER. 2018;97:33-40
- Article: MOLECULAR AND CLINICAL ONCOLOGY. 2018;8(1):141-146
- Article: ONCOIMMUNOLOGY. 2017;6(8):e1338238
- Article: ACTA ONCOLOGICA. 2017;56(1):21-26
- Article: BLOOD. 2016;128(23):2655-2665
- Article: EUROPEAN JOURNAL OF CANCER. 2016;65:43-51
- Article: ONCOLOGY LETTERS. 2016;12(2):1293-1300
- Article: MOLECULAR ONCOLOGY. 2016;10(5):719-734
- Article: JOURNAL OF EXTRACELLULAR VESICLES. 2016;5:29877
- Article: INVESTIGATIONAL NEW DRUGS. 2015;33(6):1232-1241
- Article: ONCOTARGET. 2015;6(25):21740-21754
- Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2015;46(1):381-388
- Article: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2014;32(8):1215-1224
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(2):76-82
- Article: ANTI-CANCER DRUGS. 2013;24(6):648-652
- Article: EUROPEAN UROLOGY. 2012;61(6):1229-1238
- Article: CELL DEATH & DISEASE. 2012;3(1):e262
- Article: BJU INTERNATIONAL. 2011;108(5):665-672
- Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2010;37(1):15-20
- Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2009;43(2):98-103
- Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, SUPPLEMENT. 2008;42(218):89-92
- Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2006;29(6):1517-1524
- Article: ACTA ONCOLOGICA. 2005;44(6):644-650
- Article: ACTA ONCOLOGICA. 2005;44(5):490-495
- Article: INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS. 2000;15(1):33-40
- Article: IMMUNOLOGY. 1999;97(4):656-664
- Article: CANCER RESEARCH. 1999;59(1):48-51
- Article: CLINICAL CHEMISTRY. 1996;42(10):1702-1708
- Article: CANCER RESEARCH. 1995;55(23 Suppl):5868s-5873s
- Article: CELL BIOPHYSICS. 1995;27(1):31-45
- Article: JOURNAL OF IMMUNOLOGICAL METHODS. 1995;183(1):155-165
- Article: CANCER RESEARCH. 1995;55(23):S5868-S5873
- Show more
All other publications
- Letter: SCANDINAVIAN JOURNAL OF UROLOGY. 2023;58(1):20
- Editorial comment: CANCERS. 2023;15(3):559
- Letter: ACTA ONCOLOGICA. 2022;61(12):1515-1516
- Letter: EUROPEAN UROLOGY. 2022;81(4):e92-e93
- Editorial comment: CANCERS. 2020;12(12):E3607-3607
- Review: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2019;140:80-87
- Editorial comment: ACTA ONCOLOGICA. 2019;58(7):951-952
- Letter: JAMA ONCOLOGY. 2019;5(7):1060-1062
- Letter: EUROPEAN UROLOGY. 2015;68(4):742-743
- Editorial comment: ACTA ONCOLOGICA. 2011;50:137-140
- Review: TUMOR BIOLOGY. 2008;29(5):311-322
- Letter: ACTA ONCOLOGICA. 2007;46(6):862-863
- Published conference paper: CANCER. 2002;94(4 Suppl):1314-1319
- Published conference paper: CANCER. 2002;94(4 Suppl):1306-1313
- Published conference paper: CLINICAL CANCER RESEARCH. 1999;5(10 Suppl):3073s-3078s
- Published conference paper: ACTA ONCOLOGICA. 1999;38(3):329-334
- Published conference paper: CANCER. 1997;80(12 Suppl):2689-2698
- Published conference paper: CANCER. 1997;80(12 Suppl):2681-2688
- Published conference paper: CANCER. 1997;80(12 Suppl):2510-2518
- Published conference paper: CANCER. 1997;80(12 Suppl):2404-2410
- Published conference paper: ACTA ONCOLOGICA. 1996;35(3):303-307
- Published conference paper: ACTA ONCOLOGICA. 1996;35(3):281-285
- Published conference paper: ACTA ONCOLOGICA. 1996;35(3):259-265
- Show more
Employments
- Adjunct Professor, Department of Oncology-Pathology, Karolinska Institutet, 2021-2025
Degrees and Education
- Docent, Karolinska Institutet, 2010